Keywords: pfizer, celebrex, found, cd, risks, company, halts

Pfizer's Celebrex also found to have CD risks; company halts drug's DTC ads

Article | 10 January 2005

Print This

As a result of new data showing that its best selling COX-2 inhibitor Celebrex (celecoxib), in high doses, demonstrated an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in